XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
RESTRUCTURING AND OTHER SPECIAL CHARGES
3 Months Ended
Jun. 30, 2021
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] RESTRUCTURING AND OTHER CHARGES
During the three months ended June 30, 2021, the Company recorded net restructuring and other charges of $9.6: $6.0 within Dx and $3.6 within DD. The charges were comprised of $6.1 related to severance and other personnel costs and $3.5 in facility closures, lease terminations, and general integration activities. The charges were adjusted by an increase of $0.1 of previously established severance liabilities and the reversal of previously established liability of $0.1 in unused facility-related costs.
During the six months ended June 30, 2021, the Company recorded net restructuring and other charges of $28.8: $13.5 within Dx and $15.3 within DD. The charges were comprised of $10.2 related to severance and other personnel costs and $18.7 in facility closures, lease terminations, and general integration activities. The charges were adjusted by an increase of $0.1 of previously established severance liabilities and the reversal of previously established liability of $0.2 in unused facility-related costs.
During the three months ended June 30, 2020, the Company recorded net restructuring and other special charges of $6.4: $3.7 within Dx and $2.7 within DD. The charges were comprised of $5.4 related to severance and other personnel costs, $3.3 for a DD lab facility and equipment impairment, and $4.2 in facility closures, impairment of operating lease right-of-use assets, and general integration initiatives. The charges were offset by the reversal of previously established reserves of $1.1 and $5.5 in unused severance and facility-related costs, respectively.
During the six months ended June 30, 2020, the Company recorded net restructuring and other charges of $31.8: $11.8 within Dx and $20.0 within DD. The charges were comprised of $10.5 related to severance and other personnel costs, $8.0 for a DD lab facility impairment and equipment impairments, and $20.0 in costs associated with facility closures, impairment of operating lease right-of-use assets, and general integration initiatives. The charges were offset by the reversal of previously established liability of $1.0 and $5.7 in unused severance costs and facility-related costs, respectively.
The following represents the Company’s restructuring reserve activities for the period indicated:
DxDD
Severance and Other Employee CostsFacility CostsSeverance and Other Employee CostsFacility CostsTotal
Balance as of December 31, 2020$0.3 $0.4 $2.4 $4.7 $7.8 
Restructuring charges5.2 8.4 5.0 10.3 28.9 
Adjustments to prior restructuring accruals0.1 (0.2)— — (0.1)
Cash payments and other adjustments(4.8)(8.2)(3.1)(9.1)(25.2)
Balance as of June 30, 2021$0.8 $0.4 $4.3 $5.9 $11.4 
Current  $8.9 
Non-current  2.5 
   $11.4